Cargando…

Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor

The 90 kDa heat shock protein (Hsp90) is a molecular chaperone responsible for folding proteins that are directly associated with cancer progression. Consequently, inhibition of the Hsp90 protein folding machinery results in a combinatorial attack on numerous oncogenic pathways. Seventeen small-mole...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khandelwal, Anuj, Kent, Caitlin N., Balch, Maurie, Peng, Shuxia, Mishra, Sanket J., Deng, Junpeng, Day, Victor W., Liu, Weiya, Subramanian, Chitra, Cohen, Mark, Holzbeierlein, Jeffery M., Matts, Robert, Blagg, Brian S. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789826/ https://www.ncbi.nlm.nih.gov/pubmed/29382832 http://dx.doi.org/10.1038/s41467-017-02013-1

Ejemplares similares

High-Throughput Screen of Natural Product Libraries for Hsp90 Inhibitors
por: Davenport, Jason, et al.
Publicado: (2014)

Hsp90 C-Terminal Inhibitors Exhibit Antimigratory Activity by Disrupting the Hsp90α/Aha1 Complex in PC3-MM2 Cells
por: Ghosh, Suman, et al.
Publicado: (2014)

Development and characterization of a novel C-terminal inhibitor of Hsp90 in androgen dependent and independent prostate cancer cells
por: Eskew, Jeffery D, et al.
Publicado: (2011)

Crystal structure of the middle and C-terminal domains of Hsp90α labeled with a coumarin derivative reveals a potential allosteric binding site as a drug target
por: Peng, Shuxia, et al.
Publicado: (2022)

Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma
por: Stothert, Andrew R., et al.
Publicado: (2017)

Hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors
por: Rahmy, Sharif, et al.
Publicado: (2022)

Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
por: Maiti, Samarpan, et al.
Publicado: (2022)

The Alpha Isoform of Heat Shock Protein 90 and the Co-chaperones p23 and Cdc37 Promote Opioid Anti-nociception in the Brain
por: Lei, Wei, et al.
Publicado: (2019)

Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations
por: Tomašič, Tihomir, et al.
Publicado: (2020)

Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90)
por: Mak, Oi Wei, et al.
Publicado: (2019)

The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range
por: Girstmair, Hannah, et al.
Publicado: (2019)

Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata
por: Kinnaird, Jane H., et al.
Publicado: (2016)

The disruption of protein−protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition
por: Serwetnyk, Michael A., et al.
Publicado: (2021)

Novel C‐terminal heat shock protein 90 inhibitors target breast cancer stem cells and block migration, self‐renewal, and epithelial–mesenchymal transition
por: Subramanian, Chitra, et al.
Publicado: (2020)

HSP90 inhibitors reduce cholesterol storage in Niemann-Pick type C1 mutant fibroblasts
por: Pipalia, Nina H., et al.
Publicado: (2021)

SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90
por: Lian, Bin, et al.
Publicado: (2021)

HSP90 Interacts with the Fibronectin N-terminal Domains and Increases Matrix Formation
por: Chakraborty, Abir, et al.
Publicado: (2020)

Involvement of Yeast HSP90 Isoforms in Response to Stress and Cell Death Induced by Acetic Acid
por: Silva, Alexandra, et al.
Publicado: (2013)

Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis
por: Zaki, Magdi E. A., et al.
Publicado: (2022)

Pan‐HSP90 ligand binding reveals isoform‐specific differences in plasticity and water networks
por: Stachowski, Timothy R., et al.
Publicado: (2023)

Hsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex
por: Manjarrez, Jacob R., et al.
Publicado: (2014)

Structure-Activity Relationships of Benzothiazole-Based Hsp90 C-Terminal-Domain Inhibitors
por: Dernovšek, Jaka, et al.
Publicado: (2021)

Cruentaren A Binds F(1)F(0) ATP Synthase To Modulate the Hsp90 Protein Folding Machinery
por: Hall, Jessica A., et al.
Publicado: (2014)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function
por: Collins, Colm B., et al.
Publicado: (2013)

A Dynamic View of ATP-coupled Functioning Cycle of Hsp90 N-terminal Domain
por: Zhang, Huaqun, et al.
Publicado: (2015)

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain
por: Terracciano, Stefania, et al.
Publicado: (2018)

Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization
por: Bhatia, Sanil, et al.
Publicado: (2022)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_thfeaj353mbvpq99l23vl7dg84